Search Results for: car t

SEARO RC70: India calls on WHO to take the lead in negotiations of the R&D treaty (General Programme of Work debate)

Posted on by Thiru

As noted in an earlier piece, on 25 August 2017 the WHO published a draft concept note to provide a road map to “underpin WHO’s General Programme of of Work from 2019-2023… and serve as the strategic basis for resource mobilization” for the Organization (WHO draft concept note on strategic priorities for 2019-2023 charts a new vision for the organization, 29 August 2017, KEI). Continue Reading →

2017: Nanobernetics proposed exclusive license for NIH patents on Apparatus for Microarray Binding Sensors

Posted on by Kim Treanor

(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) The attached file (copy here) is the KEI questions and initial comments on the Prospective Grant of an Exclusive Patent License: Apparatus for Microarray Binding Sensors Having… Continue Reading →

NIH response to KEI request for NIH policy on on the licensing of federally-funded CRISPR patented inventions.

Posted on by James Love

On June 6, 2017, KEI wrote to Dr. Thomas Price, Secretary of Health and Human Services (HHS), and Dr. Francis S. Collins, Director of the National Institutes of Health (NIH) requesting the HHS develop a policy on the licensing of federally-funded CRISPR patented inventions. A copy of our letter is available here: /node/2801.

Continue Reading →

KEI and Médecins Sans Frontières propose contractual terms to protect access and affordability of Zika vaccine

Posted on by Kim Treanor

25 July 2017
FOR IMMEDIATE RELEASE
CONTACT: Kim Treanor, kim.treanor@keionline.org or +1 (202) 332-2670

Washington, 25 July 2017 – Knowledge Ecology International (KEI) and Médecins Sans Frontières (MSF) have sent a letter today to the Command Judge Advocate of the U.S. Army Medical Research and Materiel Command (USAMRMC), recommending two specific contractual terms for the proposed license of the US Army’s Zika vaccine technology to Sanofi Pasteur.

Continue Reading →

House Appropriations rejects Kaptur amendment (allow competition for gov funded drugs if prices higher than reference countries)

Posted on by Kim Treanor

On 19 July 2017, Rep. Marcy Kaptur (D-OH) introduced an amendment at the markup in the U.S. House Appropriations Committee of the FY2018 State and Foreign Operations, Labor, Health and Human Services Appropriations bill that would direct the Department of Health and Human Services to use its authority to break patent monopolies for government-funded inventions priced higher in the U.S. than seven other high-income countries.

Continue Reading →

Senate Armed Services Committee directive on use of Bayh-Dole rights for DoD funded drugs

Posted on by Kim Treanor

The report of the Senate Armed Services Committee on the National Defense Authorization Act of 2018, S. 1519, published July 10, 2017, includes a directive that links exclusive patent rights to the prices of drugs, vaccines and other medical technologies that are based upon DoD-funded inventions.

The text of the directive, approved unanimously by the full Senate Armed Services Committee, is as follows:

Continue Reading →

SCP26 – Agreement reached on future work reached at WIPO Standing Committee on the Law of Patents (6 July 2017)

Posted on by Thiru

On Thursday afternoon, 6 July 2017, the 26th session of the WIPO Standing Committee on the Law of Patents (SCP), chaired by Ms. Bucura Ionescu (Romania) reached agreement on future work on the following issues: i) Exceptions and Limitations to Patent Rights, ii) Quality of Patents, including Opposition Systems, iii) Patents and Health, iv) Confidentiality of Communications between Clients and Their Patent Advisors and v) Transfer of Technology. Continue Reading →

2017: Senator Angus King amendment to National Defense Authorization Act (NDAA) on federally funded drugs, vaccines

Posted on by James Love

Angus_King,_official_portrait,_113th_Congress-800x.jpgSenator Angus King proposed an amendment to National Defense Authorization Act (NDAA) that would require the Department of Defense (DoD) to authorize third parties to use inventions that benefited from DoD research funding, when prices exceed the median price charge in the seven largest economies with per capita incomes at least half the per capita income in the United States.

Continue Reading →